Total Payments
$1,129
2024 Payments
$37.57
Companies
18
Transactions
72
Medicare Patients
1,688
Medicare Billing
$154,400
Payment Breakdown by Category
Food & Beverage$1,119 (99.1%)
Education$10.73 (0.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,119 | 71 | 99.1% |
| Education | $10.73 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $312.90 | 22 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $181.42 | 13 | $0 (2018) |
| ITI, Inc. | $109.79 | 1 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $91.25 | 7 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $87.97 | 6 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $47.79 | 4 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $43.15 | 3 | $0 (2018) |
| Lilly USA, LLC | $40.36 | 3 | $0 (2017) |
| Sanofi Pasteur Inc. | $31.65 | 2 | $0 (2018) |
| Allergan Inc. | $29.71 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $37.57 | 2 | PFIZER INC. ($19.44) |
| 2023 | $109.79 | 1 | ITI, Inc. ($109.79) |
| 2019 | $118.85 | 1 | Novo Nordisk Inc ($118.85) |
| 2018 | $522.94 | 42 | Novo Nordisk Inc ($158.74) |
| 2017 | $340.33 | 26 | Takeda Pharmaceuticals America, Inc. ($47.79) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/21/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: Endocrinology | ||||||
| 03/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $19.44 | General |
| Category: VACCINES | ||||||
| 04/06/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $109.79 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $118.85 | General |
| Category: Diabetes | ||||||
| 11/14/2018 | SANOFI-AVENTIS U.S. LLC | PRALUENT (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/07/2018 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Virology & Specialty Care | ||||||
| 11/06/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $4.32 | General |
| Category: Obesity | ||||||
| 10/24/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $10.76 | General |
| Category: Diabetes | ||||||
| 10/19/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $7.11 | General |
| Category: Obesity | ||||||
| 10/17/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/17/2018 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $6.58 | General |
| Category: Diabetes | ||||||
| 10/10/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 10/04/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $15.70 | General |
| Category: Diabetes | ||||||
| 09/12/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 09/12/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $1.15 | General |
| Category: Diabetes | ||||||
| 09/06/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $3.17 | General |
| Category: Obesity | ||||||
| 08/29/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.53 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/29/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $5.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: Obesity | ||||||
| 08/15/2018 | Novo Nordisk Inc | Saxenda (Drug) | Food and Beverage | In-kind items and services | $1.58 | General |
| Category: Obesity | ||||||
| 08/09/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $10.73 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/08/2018 | Sanofi Pasteur Inc. | MENACTRA (Drug), FLUZONE HIGH-DOSE, ADACEL | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: VACCINES | ||||||
| 07/31/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $2.63 | General |
| Category: Diabetes | ||||||
| 07/18/2018 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 435 | 612 | $112,994 | $40,953 |
| 2022 | 11 | 416 | 557 | $80,911 | $39,110 |
| 2021 | 10 | 416 | 566 | $76,782 | $40,218 |
| 2020 | 11 | 421 | 525 | $74,535 | $34,119 |
Total Patients
1,688
Total Services
2,260
Medicare Billing
$154,400
Procedure Codes
41
All Medicare Procedures & Services
41 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 271 | $66,395 | $20,449 | 30.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 107 | 107 | $26,750 | $12,897 | 48.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 26 | 26 | $3,458 | $1,971 | 57.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 12 | $4,152 | $1,606 | 38.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 30 | 32 | $5,407 | $1,578 | 29.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $1,666 | $981.58 | 58.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 63 | 98 | $3,724 | $919.18 | 24.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $882.00 | $519.66 | 58.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 14 | 14 | $560.00 | $30.80 | 5.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 134 | 254 | $41,956 | $18,085 | 43.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 91 | 91 | $20,234 | $11,187 | 55.3% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 11 | 11 | $3,311 | $2,474 | 74.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $4,044 | $2,059 | 50.9% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 27 | 27 | $3,565 | $1,897 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 26 | $2,944 | $953.19 | 32.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 30 | 31 | $1,519 | $843.37 | 55.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 47 | 63 | $1,827 | $586.71 | 32.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 11 | 13 | $546.00 | $533.39 | 97.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 17 | 17 | $833.00 | $466.00 | 55.9% |
| 85018 | Blood count, hemoglobin | Office | 2022 | 11 | 11 | $132.00 | $25.52 | 19.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 135 | 258 | $39,216 | $20,343 | 51.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 90 | 90 | $19,440 | $11,381 | 58.5% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 13 | 13 | $4,225 | $2,114 | 50.0% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 31 | 31 | $3,317 | $1,958 | 59.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 11 | 11 | $3,366 | $1,793 | 53.3% |
About Dr. David Gaines, MD
Dr. David Gaines, MD is a Family Medicine healthcare provider based in Watkinsville, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386613784.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Gaines, MD has received a total of $1,129 in payments from pharmaceutical and medical device companies, with $37.57 received in 2024. These payments were reported across 72 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,119).
As a Medicare-enrolled provider, Gaines has provided services to 1,688 Medicare beneficiaries, totaling 2,260 services with total Medicare billing of $154,400. Data is available for 4 years (2020–2023), covering 41 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Watkinsville, GA
- Active Since 03/16/2006
- Last Updated 10/25/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386613784
Products in Payments
- FARXIGA (Drug) $168.48
- Ozempic (Drug) $136.19
- Victoza (Drug) $122.90
- CAPLYTA (Drug) $109.79
- TRADJENTA (Drug) $58.01
- Saxenda (Drug) $53.81
- TOUJEO (Drug) $50.57
- Trintellix (Drug) $34.33
- JANUVIA (Drug) $32.84
- ZOSTAVAX (Biological) $31.50
- NAMZARIC (Drug) $29.71
- SOLIQUA (Drug) $28.55
- CONTRAVE (Drug) $26.03
- TRULICITY (Drug) $25.50
- ASMANEX (Drug) $23.63
- Prolia (Biological) $22.54
- PREVNAR 20 (Biological) $19.44
- Dexcom G6 Transmitter (Medical Supply) $18.13
- Xofluza (Drug) $17.83
- ADVAIR (Drug) $17.67
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Watkinsville
Dr. Mark Earhart, M.d, M.D
Family Medicine — Payments: $16,607
Family Medicine $16,607
Dr. Raymond Gilbert, M.d, M.D
Family Medicine — Payments: $10,797
Family Medicine $10,797
Dr. Thomas Mcelhannon, Md, MD
Family Medicine — Payments: $5,442
Family Medicine $5,442
Dr. Dennis Bullock, Md, MD
Family Medicine — Payments: $3,954
Family Medicine $3,954
Dr. Keith Zimmerman, Md, MD
Family Medicine — Payments: $2,352
Family Medicine $2,352
Dr. Kirk Melville, Md, MD
Family Medicine — Payments: $2,257
Family Medicine $2,257